Dr. Arturo Bonometti is an Italian pathologist especially interested in histiocytic and myeloid neoplasms. He is Assistant Professor of Pathology at Humanitas University, Milan, Italy, and hematopathologist, soft tissue pathologist and molecular pathologist at the IRCCS Humanitas Clinical and Research Hospital. He received his MD in Medicine and Surgery from the Faculty of Medicine and Surgery of the University of Milan, and has been resident in Pathology at the Unit of Anatomic Pathology of the University of Pavia. His research interests mainly include the classification, clinical and histopathological characterization of histiocytic disorders, the immune microenvironment of hematological neoplasms, and the characterization of rare hematological neoplasms, including those involving the skin. He is a member of the European Bone Marrow Working Group (EBMWG), and the European society of hematopathology (EAH4P), and he is also a member and volunteer of the Italian Association for the Research on Histiocytosis (Associazione Italiana Ricerca Istiocitosi, AIRI, ONLUS).
Prof. Dr. Matteo Giovanni Della Porta has a position as a Full Professor of Hematology and is currently working at the Department of Biomedical Sciences, Humanitas University, Milan, Italy. He obtained his Medical Degree with honors at the University of Pavia Medical School, Pavia, Italy in 1999. From 2000 to 2003 he completed his training in Hematology at the Department of Hematology, University of Ferrara Medical School, Ferrara, Italy, and obtained his Degree with honors. From 2004 to 2006 he was awarded a postdoctoral fellowship at the Department of Hematology, University of Pavia Medical School & S. Matteo Hospital, Pavia, Italy. Since 2008 he has held the position of Associate Professor of Clinical Oncology at the University of Pavia Medical School & S. Matteo Hospital, Pavia, Italy. In 2008 he joined the European LeukemiaNet working package on myelodysplastic syndromes, aimed at developing European evidence and consensus-based guidelines for the diagnosis and treatment of myelodysplastic syndromes. In 2010, he joined the International Cancer Genome Consortium Chronic Myeloid Disorders Working Group. Since 2016 he has held the position of the Head of the Leukemia Unit–Cancer Center, Humanitas Research Hospital. His current research interests mainly concern acute leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms (myeloid malignancies).
